Exhibit 15.1
Consent of Independent Registered Public Accounting Firm
Addex Therapeutics Ltd
Geneva, Switzerland
We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-255089) and Form S-8 (No. 333-255124) of Addex Therapeutics Ltd (the Company) of our report dated May 15, 2025, relating to the consolidated financial statements appearing in the Company’s Annual Report on Form 20-F for the year ended December 31, 2024.
BDO AG
/s/ Christoph Tschumi | /s/ Nigel Le Masurier |
| |
Zurich, Switzerland, May 15, 2025 | |
Consent of Independent Registered Public Accounting Firm
Neurosterix US Holding LLC
Delaware, USA
We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-255089) and Form S-8 (No. 333-255124) of our report dated May 15, 2025, relating to the Neurosterix US Holding LLC consolidated financial statements appearing in Addex Therapeutics Ltd’s Annual Report on Form 20-F for the year ended December 31, 2024.
BDO AG
/s/ Christoph Tschumi | /s/ Nigel Le Masurier |
| |
Zurich, Switzerland, May 15, 2025 | |